Chemical Structure (Ampyra 01)
Chemical structure of the active ingredient Dalfampridine, showing a pyridine ring with an amino group attached.*
Ampyra Tablet, Film Coated, Extended Release
Product Images NDC 0259-5010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ampyra (NDC 0259-5010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merz Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ampyra 02)
A bar chart comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline between placebo (N=72) and AMPYRA 10 mg twice daily (N=224). The chart includes p-values at each threshold, showing statistically significant differences at lower thresholds and no significant differences at higher thresholds.*
Figure 2 (Ampyra 03)
Bar graph comparing the percentage of patients showing various average percent increases in walking speed from baseline between placebo (N=118) and AMPYRA 10 mg twice daily (N=119). The x-axis represents walking speed increase categories from ≥0% to ≥60%, and the y-axis shows the percentage of patients. P values are provided for each comparison showing statistical significance in most categories in favor of AMPYRA.*
Principal Display Panel (10 mg Tablet Bottle Label)
Label for AMPYRA (dalfampridine) Extended Release Tablets, 10 mg strength. The label indicates the product is an oral tablet in extended release form, distributed by Merz Pharmaceuticals, LLC. The package contains 60 tablets, with instructions for pharmacist dispensing. The label includes the NDC 0259-5010-60 and warnings about dosage, storage, and keeping out of reach of children.*
Crcl-eqn-102716.jpg (Crcl Eqn 102716)
A formula showing calculation of creatinine clearance (CrCl) based on age, weight in kilograms, serum creatinine concentration in mg/dl, and constants. This is a mathematical equation, not a chemical structure, associated with renal function assessment.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
